echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Int J Urol: How effective is cabazide in patients with metastatic castration-resistant prostate cancer?

    Int J Urol: How effective is cabazide in patients with metastatic castration-resistant prostate cancer?

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cabazil is a new generation of yew drugs


    Recently, researchers from Japan published an article in World J Urol analyzing the clinical indicators


    The researchers conducted a retrospective study


    The study eventually included 57 patients who received cabataraces (median 4 cycles, range 1-27) starting at a starting dose of 15-25 mg/m2


    Prognostic analysis of overall survival in baseline factors after CBZ treatment

    In summary, previous androgen receptor-targeted therapy is the only risk factor


    Original Source:

    Yoshiyuki Yamamoto , Makoto Ishii , Akihiro Yoshimura et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.